Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.387 USD | -4.94% | -1.67% | -14.39% |
Mar. 20 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
Mar. 18 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.39% | 30.16M | |
+25.58% | 42.68B | |
-2.81% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.45% | 24.94B | |
-20.32% | 18.96B | |
+29.16% | 12.3B | |
-2.69% | 11.95B | |
-1.37% | 11.55B |
- Stock Market
- Equities
- OMIC Stock
- News Singular Genomics Systems, Inc.
- Transcript : Singular Genomics Systems, Inc. Presents at UBS MedTech, Tools and Genomics Summit 2023, Aug-16-2023 09